ATE330621T1 - Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden - Google Patents

Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden

Info

Publication number
ATE330621T1
ATE330621T1 AT00923345T AT00923345T ATE330621T1 AT E330621 T1 ATE330621 T1 AT E330621T1 AT 00923345 T AT00923345 T AT 00923345T AT 00923345 T AT00923345 T AT 00923345T AT E330621 T1 ATE330621 T1 AT E330621T1
Authority
AT
Austria
Prior art keywords
materials
soft tissue
cross
production
methods
Prior art date
Application number
AT00923345T
Other languages
English (en)
Inventor
Norman Orentreich
Rozlyn A Krajcik
Original Assignee
Orentreich Foundation For The
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orentreich Foundation For The filed Critical Orentreich Foundation For The
Application granted granted Critical
Publication of ATE330621T1 publication Critical patent/ATE330621T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Fiber Materials (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Materials For Medical Uses (AREA)
AT00923345T 1999-05-11 2000-04-13 Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden ATE330621T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/309,689 US7015198B1 (en) 1999-05-11 1999-05-11 Materials for soft tissue augmentation and methods of making and using same

Publications (1)

Publication Number Publication Date
ATE330621T1 true ATE330621T1 (de) 2006-07-15

Family

ID=23199244

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00923345T ATE330621T1 (de) 1999-05-11 2000-04-13 Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden

Country Status (7)

Country Link
US (1) US7015198B1 (de)
EP (1) EP1178816B1 (de)
AT (1) ATE330621T1 (de)
AU (1) AU4348800A (de)
CA (1) CA2371265A1 (de)
DE (1) DE60028965T2 (de)
WO (1) WO2000067774A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070078435A1 (en) * 2001-06-14 2007-04-05 Corbett Stone Tissue augmentation methods using a medical injection apparatus
EP1507543A4 (de) * 2002-05-09 2006-07-26 Cambridgemed Inc Pharmazeutische zusammensetzung zur behandlung von wunden mit blutplasma oder serum
US20050276863A1 (en) * 2004-05-27 2005-12-15 Medtronic Vascular, Inc. Methods for treatment of aneurysmal tissue
US20070102010A1 (en) * 2005-10-07 2007-05-10 Lemperle Stefan M Naso-pharyngeal tissue engineering
EP2049560B1 (de) 2006-07-13 2013-05-15 Novozymes Biopharma DK A/S Verfahren zur herstellung von partikeln aus proteinhaltigem material
EP2203129A4 (de) * 2007-10-15 2011-11-23 Univ Wake Forest Health Sciences Verfahren und zusammensetzungen zum bedrucken von biokompatiblen nanoröhren-kompositen aus autologem gewebe
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US9101538B2 (en) 2009-05-20 2015-08-11 Donna M. Tozzi Injectable amino-acid composition
US20100297182A1 (en) * 2009-05-20 2010-11-25 Tozzi Donna M Injectable Amino-acid Composition
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
ES2585388T5 (es) * 2010-03-22 2019-08-08 Allergan Inc Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
KR102312056B1 (ko) 2011-06-03 2021-10-12 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
ES2527967B1 (es) * 2013-08-01 2015-12-28 Biotechnology Institute, I Mas D, S.L. Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas y método de preparación de la misma
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
PL3256179T3 (pl) 2015-02-13 2020-05-18 Allergan Industrie, Sas Implanty do kształtowania, uwydatniania lub korygowania cech twarzy takich jak broda

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3152976A (en) 1961-09-21 1964-10-13 Ethicon Inc Preparation of collagenous materials
DE1276650B (de) 1962-05-11 1968-09-05 Iabiotestia Serum Inst G M B H Verfahren zur Herstellung von als Blutplasmaersatzmittel geeigneten, modifizierten Proteinzubereitungen
US4046871A (en) * 1975-04-08 1977-09-06 Ortho Diagnostics Inc. Compositions and serological methods including bovine serum albumin polymers
US4006220A (en) 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars
US4404970A (en) 1978-05-19 1983-09-20 Sawyer Philip Nicholas Hemostatic article and methods for preparing and employing the same
US5628781A (en) 1985-06-06 1997-05-13 Thomas Jefferson University Implant materials, methods of treating the surface of implants with microvascular endothelial cells, and the treated implants themselves
US5147514A (en) 1987-08-02 1992-09-15 University Of North Carolina Process for cross-linking collagenous material and resulting product
US4969912A (en) 1988-02-18 1990-11-13 Kelman Charles D Human collagen processing and autoimplant use
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5550187A (en) 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
US5527856A (en) 1988-11-21 1996-06-18 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
AT398276B (de) 1989-05-31 1994-11-25 Sorin Biomedica Spa Verfahren zur präparierung von biologischem implantationsmaterial
WO1994002183A1 (en) 1992-07-27 1994-02-03 Haemacure Biotech Inc. Biocompatible surgical implant
CN1091315A (zh) 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5733545A (en) 1995-03-03 1998-03-31 Quantic Biomedical Partners Platelet glue wound sealant
US6020181A (en) * 1995-05-17 2000-02-01 New York Blood, Inc. Inhibition of thrombus formation by medical related apparatus comprising treating with fibrinolytic matrix metalloproteinase

Also Published As

Publication number Publication date
EP1178816B1 (de) 2006-06-21
US7015198B1 (en) 2006-03-21
CA2371265A1 (en) 2000-11-16
DE60028965T2 (de) 2007-03-29
DE60028965D1 (de) 2006-08-03
AU4348800A (en) 2000-11-21
EP1178816A2 (de) 2002-02-13
WO2000067774A3 (en) 2001-02-08
WO2000067774A2 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
ATE330621T1 (de) Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden
ATE250399T1 (de) Gebrauch von autologen, dermalen fibroblasten zur reperatur von haut- oder weichgewebeschäden
AU573626B2 (en) Protein/polysaccharide complexes as wound dressing
FR2767833B1 (fr) Polypeptide isole de l'epiderme et son utilisation
ATE176924T1 (de) Verfahren zur herstellung von menschlicher dnase
WO2004076631A3 (en) Biologically active native biomatrix composition
ATE110782T1 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
ATE314102T1 (de) Verwendung einer kollagenmembrane zur herstellung eines implantates für gesteuerte geweberegeneration
MY140581A (en) Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
ATE552864T1 (de) Therapeutisch aktive wundauflagen, deren herstellung und deren verwendung
DE69736391D1 (de) Verfahren zur herstellung eines rekombinanten polypeptids unter hinzufügung eines hemmstoffes einer metallabhängigen protease oder chymotrypsins zum zellkulturmedium
Kim et al. Evaluation of an amniotic membrane-collagen dermal substitute in the management of full-thickness skin defects in a pig
Spira et al. Human amnion collagen for soft tissue augmentation—biochemical characterizations and animal observations
KR940005799A (ko) 거핵구 분화 인자
NO971341D0 (no) Promoter for reseptor tyrosinkinase TIE
HUP9901188A2 (hu) Új, meghatározott enzimkeverékek sejtkinyeréshez és sebkezeléshez
DE60135291D1 (de) Verfahren zur Herstellung von Naturkautschuklatex mit geringer allergischer Wirkung und von deproteinisiertem Naturkautschuklatex und Naturkautschuklatex mit geringer allergischer Wirkung und deproteinisierter Naturkautschuklatex
Ehrlich Marine collagens
US20040213753A1 (en) Method for stimulating cell growth using sponge protein hydrolysates
CN114591419B (zh) 一种热水解蛋白及其制备方法和应用
CA2086835A1 (en) Tissue plasminogen activator variants with decreased clearance
Shono et al. The structure proteins of the human nail
CA1077837A (en) Hydrolytic enzyme material
Sawyer Scientific rationale behind the medical use of leeches
ATE283284T1 (de) Verfahren zur herstellung von wespengift- allergenen mit verminderter ige-reaktivität

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties